𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Combined and alternating ganciclovir/ foscarnet in HIV-related cytomegalovirus encephalitis

✍ Scribed by Peters, Malte; Schürmann, Dirk; Pohle, HansD; Ruf, Bernhard; Timm, Harald

Book ID
123212855
Publisher
The Lancet
Year
1992
Tongue
English
Weight
140 KB
Volume
340
Category
Article
ISSN
0140-6736

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combined and alternating ganciclovir and
Combined and alternating ganciclovir and foscarnet in acute and maintenance therapy of human immunodeficiency virus-related cytomegalovirus encephalitis refractory to ganciclovir alone
✍ Peters, M. ;Timm, U. ;Sch�rmann, D. ;Pohlel, H.D. ;Ruf, B. 📂 Article 📅 1992 🏛 Springer-Verlag 🌐 English ⚖ 351 KB

Cytomegalovirus (CMV) causes life-threatening disseminated infections and in particular vision-threatening infections of the retina in patients with the acquired immunodeficiency syndrome. Ganciclovir currently represents the most frequently used therapy for CMV retinitis. However, cases of ganciclo

Foscarnet and ganciclovir pharmacokineti
Foscarnet and ganciclovir pharmacokinetics during concomitant or alternating maintenance therapy for AIDS-related cytomegalovirus retinitis*
✍ Aweeka, Francesca T.; Gambertoglio, John G.; Kramer, Françoise; van der Horst, 📂 Article 📅 1995 🏛 Nature Publishing Group 🌐 English ⚖ 849 KB

Introdwtiun: The we of foscarnet and ganciclovir as a combination treatment for cytomegalovirus retinitis is increasing because of limitations associated with single agent therapy. Methal: The pharmacokinetics of foscarnet and ganciclovir were determined in 13 patients receiving either concomitant t

Resistance to combined ganciclovir and f
Resistance to combined ganciclovir and foscarnet therapy in a liver transplant recipient with possible dual-strain cytomegalovirus coinfection
✍ John Rodriguez; Katherine Casper; Gregory Smallwood; Andrei Stieber; Carlos Faso 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB

We present a case report of a cytomegalovirus (CMV)-seronegative, 58-year-old male who received a CMV-seropositive donor liver transplant without CMV prophylaxis. On postoperative day 30, the patient developed primary CMV disease that responded to ganciclovir. On postoperative day 114, however, he w